Skip to main content
Fig. 7 | BMC Complementary and Alternative Medicine

Fig. 7

From: Chemopreventive and immunomodulatory effects of Murraya koenigii aqueous extract on 4T1 breast cancer cell-challenged mice

Fig. 7

Cocultivation Cytotoxicity: Cytotoxicity level of splenocyte on Yac-1 at E: T ratio of 2 : 1 and 10 : 1 from different treatment groups on day 21 after 4T1 cell inoculation. Each value represents the means ± S.D. for three mice in triplicate each. The differences between the control or treated group and untreated group were determined by one-way ANOVA (for low risk groups while #for high risk groups; p < 0.05). Normal: normal healthy mice; LR untreated: untreated low risk mice inoculated with 1 × 1044T1 cell/mice; LR MK 50 mg/kg: low risk mice treated with 50 mg/kg of MK extract for 30 days before inoculated with 1 × 1044T1 cell/mice; LR MK 200 mg/kg: low risk mice treated with 200 mg/kg of MK extract for 30 days before inoculated with 1 × 1044T1 cell/mice; HR untreated: untreated high risk mice inoculated with 1 × 1064T1 cell/mice; HR MK 50 mg/kg: high risk mice treated with 50 mg/kg of MK extract for 30 days before inoculated with 1 × 1064T1 cell/mice; HR MK 200 mg/kg: high risk mice treated with 200 mg/kg of MK extract for 30 days before inoculated with 1 × 1064T1 cell/mice inoculated mice. LR: Low risk groups. HR: High risk groups

Back to article page